| scholarly article | Q13442814 |
| P2093 | author name string | R A Harris | |
| Å Lernmark | |||
| C M Cilio | |||
| K Lynch | |||
| C-D Agardh | |||
| C Silver | |||
| M Radenkovic | |||
| J Arvastsson | |||
| P2860 | cites work | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 |
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| Role of the B7-CD28/CTLA-4 pathway in autoimmune disease | Q28217357 | ||
| Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease | Q28265611 | ||
| Multiple immuno-regulatory defects in type-1 diabetes | Q28344695 | ||
| FOXP3+ regulatory T cells in the human immune system | Q29307487 | ||
| Regulatory T cells and immune tolerance | Q29616864 | ||
| Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. | Q34553677 | ||
| Latent autoimmune diabetes in adults: A distinct but heterogeneous clinical entity | Q34628948 | ||
| CTLA-4: new insights into its biological function and use in tumor immunotherapy | Q34711491 | ||
| Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study | Q36249785 | ||
| LADA: time for a new definition | Q36560625 | ||
| Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society | Q37799656 | ||
| Treg and CTLA-4: two intertwining pathways to immune tolerance | Q38121260 | ||
| Is CD69 an effective brake to control inflammatory diseases? | Q38129638 | ||
| Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells | Q40425444 | ||
| Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species | Q46638473 | ||
| Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. | Q51565693 | ||
| Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. | Q51634813 | ||
| Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients. | Q54095939 | ||
| Abnormal DNA methylation in CD4+ T cells from people with latent autoimmune diabetes in adults. | Q54352401 | ||
| Altered natural killer cells in type 1 diabetic patients. | Q54565253 | ||
| Role of the B7-CD28/CTLA-4 Pathway in Autoimmune Disease | Q55879904 | ||
| CD4+CD25high regulatory cells in human peripheral blood | Q56905059 | ||
| CD69: an unexpected regulator of TH17 cell-driven inflammatory responses | Q58063887 | ||
| Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells | Q58234949 | ||
| Cutting Edge: Increased IL-17-Secreting T Cells in Children with New-Onset Type 1 Diabetes | Q58328293 | ||
| Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4 | Q61478347 | ||
| A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM | Q61861656 | ||
| Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency | Q72066129 | ||
| The World Health Organization International Collaborative Study for islet cell antibodies | Q73193778 | ||
| The CD4(+) regulatory T-cells is decreased in adults with latent autoimmune diabetes | Q79148398 | ||
| No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes | Q79843142 | ||
| CD4+CD25high regulatory T cells in human autoimmune diabetes | Q81428869 | ||
| Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes | Q81690799 | ||
| Abnormal T cell autoimmunity against GAD65 in LADA patients | Q82077060 | ||
| Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency | Q84086506 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | phenotype | Q104053 |
| P304 | page(s) | 46-56 | |
| P577 | publication date | 2016-06-30 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA). | |
| P478 | volume | 186 |
| Q92186396 | Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes |
| Q90324457 | Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes |
| Q64983630 | Downregulation of T-Cell Transcription Factors in Adult Latent Autoimmune Diabetes with High-Titer Glutamic Acid Decaroxylase Antibody. |
| Q58065034 | First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes |
| Q28555177 | Glibenclamide Prevents Diabetes in NOD Mice |
| Q91984134 | Past, present and future of latent autoimmune diabetes in adults |
| Q41787689 | Reduced Histone H3 Lysine 9 Methylation Contributes to the Pathogenesis of Latent Autoimmune Diabetes in Adults via Regulation of SUV39H2 and KDM4C. |
| Q92431877 | Transcriptome profiling of microRNAs associated with latent autoimmune diabetes in adults (LADA) |
Search more.